{"id":8134,"date":"2021-04-12T11:41:13","date_gmt":"2021-04-12T10:41:13","guid":{"rendered":"https:\/\/www.heartfailurematters.org\/vad-kan-din-lakare-gora\/sglt2-hammare-natrium-glukostransportorer-2\/"},"modified":"2026-02-10T13:33:21","modified_gmt":"2026-02-10T13:33:21","slug":"sglt2-hammare-natrium-glukostransportorer-2","status":"publish","type":"page","link":"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/","title":{"rendered":"SGLT2 (Sodium Glucose Cotransporter 2) inhibitors"},"content":{"rendered":"<p><strong>L\u00f6sligt guanylatcyklas stimulerare (sGCS)<\/strong> och aktivatorer minskar oxidativ stress genom att \u00f6ka niv\u00e5erna av kv\u00e4veoxid i hj\u00e4rta och blodk\u00e4rl. Dessa l\u00e4kemedel \u00e4r nya inom hj\u00e4rtsviktsbehandling och \u00e4nnu inte lika allm\u00e4nt f\u00f6rekommande som andra l\u00e4kemedel. Ett s\u00e5dant sGCS-medel \u00e4r vericiguat som n\u00e4r det anv\u00e4nds i kombination med standardl\u00e4kemedel kan bidra till att f\u00f6rhindra sjukhusvistelser hos patienter med sv\u00e5r hj\u00e4rtsvikt. Ett annat sGCS-medel \u00e4r riociguat, vilket \u00e4r godk\u00e4nt f\u00f6r behandling av ett specifikt tillst\u00e5nd som kallas lunghypertoni (pulmonell hypertension), dvs. ett \u00f6kat tryck i lungorna som skadar blodk\u00e4rlen.<\/p>\n<p>Nyligen genomf\u00f6rda studier har ocks\u00e5 visat att dessa l\u00e4kemedel kan minska risken f\u00f6r hj\u00e4rtd\u00f6d och \u00e5terinl\u00e4ggningar p\u00e5 sjukhus och \u00e4r s\u00e4kra och effektiva f\u00f6r patienter som lider av hj\u00e4rtsvikt, \u00e4ven om de inte har diabetes.<\/p>\n<p>SGLT2-h\u00e4mmare \u00e4r en klass l\u00e4kemedel som har anv\u00e4nts f\u00f6r behandling av patienter med typ 2-diabetes. Nya studier har visat att dessa l\u00e4kemedel ger l\u00e4ngre livsl\u00e4ngd och minskar sjukhusvistelser hos patienter med hj\u00e4rtsvikt och \u00e4ven skyddar njurfunktionen. Dessa positiva effekter observerades b\u00e5de hos patienter med och utan diabetes.<\/p>\n<p><strong>Hur de fungerar<\/strong> Hos patienter med hj\u00e4rtsvikt \u00e4r effekterna av SGLT2-h\u00e4mmare i kroppen komplexa. De innefattar bland annat f\u00f6rb\u00e4ttrad hj\u00e4rt- och muskelmetabolism, f\u00f6rb\u00e4ttrad njurfunktion samt en l\u00e4tt v\u00e4tskedrivande effekt, vilka alla kan lindra symtom av \u00f6verv\u00e4tskning vid hj\u00e4rtsvikt \u2013 oavsett om patienten har diabetes eller inte.<\/p>\n<p>Hos patienter med diabetes blockerar SGLT2-h\u00e4mmare \u00e5terabsorptionen av blodsocker (glukos) i njurarna. Detta leder till att mer glukos uts\u00f6ndras fr\u00e5n kroppen och m\u00e4ngden urinering \u00f6kar n\u00e5got. P\u00e5 s\u00e5 s\u00e4tt s\u00e4nker SGLT2-h\u00e4mmare blodglukosniv\u00e5erna. Patienter g\u00e5r i allm\u00e4nhet ner i vikt medan blodtrycket i viss m\u00e5n kan s\u00e4nkas.<\/p>\n<p>Vilka \u00e4r de f\u00f6rv\u00e4ntade f\u00f6rdelarna? Hos patienter med hj\u00e4rtsvikt har SGLT2-h\u00e4mmare visat sig kunna minska antalet hj\u00e4rtsviktsrelaterade sjukhusvistelser, f\u00f6rl\u00e4nga livet, f\u00f6rebygga njurproblem samt f\u00f6rb\u00e4ttra ork och livskvalitet. SGLT2-h\u00e4mmare s\u00e4nker blodglukosniv\u00e5n hos patienter med diabetes men inte hos patienter utan typ-II-diabetes.<\/p>\n<p><strong>Biverkningar:<\/strong> SGLT2-h\u00e4mmare tolereras i allm\u00e4nhet v\u00e4l av patienter med hj\u00e4rtsvikt och ger loka mycket biverkningar som placebo. Hos patienter med typ 2-diabetes \u00e4r de vanligaste biverkningarna svampinfektioner i underlivet, som oftast kr\u00e4ver lokal behandling (med kr\u00e4m) i flera dagar. Mer s\u00e4llsynta biverkningar innefattar yrsel om blodtrycket sjunker och f\u00f6rs\u00e4mrad njurfunktion. Vanligtvis \u00e4r justering av andra orala glukoss\u00e4nkande l\u00e4kemedel eller diuretika inte n\u00f6dv\u00e4ndigt, men ibland kan det vara gynnsamt. Diabetespatienter som tar SGLT2-h\u00e4mmare b\u00f6r vara f\u00f6rsiktiga under perioder av allvarlig sjukdom, uttorkning eller om de slutar ta sitt insulin, eftersom detta har kopplats till diabetesketoacidos, med h\u00f6ga niv\u00e5er av glukos, vilket \u00e4r ett allvarligt medicinskt tillst\u00e5nd som kr\u00e4ver omedelbar medicinsk behandling.<\/p>\n<p>Tips: SGLT2-h\u00e4mmare kan s\u00e4ttas in eller stoppas p\u00e5 ett s\u00e4kert s\u00e4tt genom en gradvis \u00f6kning eller minskning av dosen. Vanligtvis \u00e4r startdosen ocks\u00e5 den maximala dosen.<\/p>\n<h2>\u00c4ven k\u00e4nd som:<\/h2>\n<ul>\n<li><strong>Kanagliflozin<\/strong><br \/>\n(Invokana\u00ae)<\/li>\n<li><strong>Dapagliflozin<\/strong><br \/>\n(Forxiga\u00ae)<\/li>\n<li><strong>Empagliflozin<\/strong><br \/>\n(Jardiance\u00ae).<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L\u00f6sligt guanylatcyklas stimulerare (sGCS) och aktivatorer minskar oxidativ stress genom att \u00f6ka niv\u00e5erna av kv\u00e4veoxid i hj\u00e4rta och blodk\u00e4rl. Dessa l\u00e4kemedel \u00e4r nya inom hj\u00e4rtsviktsbehandling och \u00e4nnu inte lika allm\u00e4nt f\u00f6rekommande som andra l\u00e4kemedel. Ett s\u00e5dant sGCS-medel \u00e4r vericiguat som n\u00e4r det anv\u00e4nds i kombination med standardl\u00e4kemedel kan bidra till att f\u00f6rhindra sjukhusvistelser hos patienter [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":10874,"parent":2685,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-8134","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>SGLT2-h\u00e4mmare och hj\u00e4rtsvikt<\/title>\n<meta name=\"description\" content=\"SGLT2-h\u00e4mmare (natrium-glukostransport\u00f6rer 2) anv\u00e4nds f\u00f6r behandling av patienter med typ 2-diabetes och hj\u00e4rtsvikt.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SGLT2-h\u00e4mmare och hj\u00e4rtsvikt\" \/>\n<meta property=\"og:description\" content=\"SGLT2-h\u00e4mmare (natrium-glukostransport\u00f6rer 2) anv\u00e4nds f\u00f6r behandling av patienter med typ 2-diabetes och hj\u00e4rtsvikt.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Heart Failure Matters\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/heartfailurematters\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-10T13:33:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.heartfailurematters.org\/wp-content\/uploads\/2022\/03\/shutterstock_441673426-1-min.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"596\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/\",\"url\":\"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/\",\"name\":\"SGLT2-h\u00e4mmare och hj\u00e4rtsvikt\",\"isPartOf\":{\"@id\":\"https:\/\/www.heartfailurematters.org\/sv\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.heartfailurematters.org\/wp-content\/uploads\/2022\/03\/shutterstock_441673426-1-min.jpg\",\"datePublished\":\"2021-04-12T10:41:13+00:00\",\"dateModified\":\"2026-02-10T13:33:21+00:00\",\"description\":\"SGLT2-h\u00e4mmare (natrium-glukostransport\u00f6rer 2) anv\u00e4nds f\u00f6r behandling av patienter med typ 2-diabetes och hj\u00e4rtsvikt.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/#primaryimage\",\"url\":\"https:\/\/www.heartfailurematters.org\/wp-content\/uploads\/2022\/03\/shutterstock_441673426-1-min.jpg\",\"contentUrl\":\"https:\/\/www.heartfailurematters.org\/wp-content\/uploads\/2022\/03\/shutterstock_441673426-1-min.jpg\",\"width\":900,\"height\":596},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\/\/www.heartfailurematters.org\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vad din l\u00e4kare kan g\u00f6ra\",\"item\":\"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"SGLT2 (Sodium Glucose Cotransporter 2) inhibitors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.heartfailurematters.org\/sv\/#website\",\"url\":\"https:\/\/www.heartfailurematters.org\/sv\/\",\"name\":\"Heart Failure Matters\",\"description\":\"Practical information for patients, families and caregivers.\",\"publisher\":{\"@id\":\"https:\/\/www.heartfailurematters.org\/sv\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.heartfailurematters.org\/sv\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.heartfailurematters.org\/sv\/#organization\",\"name\":\"Heart Failure Matters\",\"url\":\"https:\/\/www.heartfailurematters.org\/sv\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\/\/www.heartfailurematters.org\/sv\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cdn-endpoint-hfm.azureedge.net\/heartfailurematters\/2024\/07\/hfm-logo1.jpg\",\"contentUrl\":\"https:\/\/cdn-endpoint-hfm.azureedge.net\/heartfailurematters\/2024\/07\/hfm-logo1.jpg\",\"width\":1280,\"height\":720,\"caption\":\"Heart Failure Matters\"},\"image\":{\"@id\":\"https:\/\/www.heartfailurematters.org\/sv\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/heartfailurematters\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SGLT2-h\u00e4mmare och hj\u00e4rtsvikt","description":"SGLT2-h\u00e4mmare (natrium-glukostransport\u00f6rer 2) anv\u00e4nds f\u00f6r behandling av patienter med typ 2-diabetes och hj\u00e4rtsvikt.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/","og_locale":"sv_SE","og_type":"article","og_title":"SGLT2-h\u00e4mmare och hj\u00e4rtsvikt","og_description":"SGLT2-h\u00e4mmare (natrium-glukostransport\u00f6rer 2) anv\u00e4nds f\u00f6r behandling av patienter med typ 2-diabetes och hj\u00e4rtsvikt.","og_url":"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/","og_site_name":"Heart Failure Matters","article_publisher":"https:\/\/www.facebook.com\/heartfailurematters","article_modified_time":"2026-02-10T13:33:21+00:00","og_image":[{"width":900,"height":596,"url":"https:\/\/www.heartfailurematters.org\/wp-content\/uploads\/2022\/03\/shutterstock_441673426-1-min.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"3 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/","url":"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/","name":"SGLT2-h\u00e4mmare och hj\u00e4rtsvikt","isPartOf":{"@id":"https:\/\/www.heartfailurematters.org\/sv\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/#primaryimage"},"image":{"@id":"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.heartfailurematters.org\/wp-content\/uploads\/2022\/03\/shutterstock_441673426-1-min.jpg","datePublished":"2021-04-12T10:41:13+00:00","dateModified":"2026-02-10T13:33:21+00:00","description":"SGLT2-h\u00e4mmare (natrium-glukostransport\u00f6rer 2) anv\u00e4nds f\u00f6r behandling av patienter med typ 2-diabetes och hj\u00e4rtsvikt.","breadcrumb":{"@id":"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/#primaryimage","url":"https:\/\/www.heartfailurematters.org\/wp-content\/uploads\/2022\/03\/shutterstock_441673426-1-min.jpg","contentUrl":"https:\/\/www.heartfailurematters.org\/wp-content\/uploads\/2022\/03\/shutterstock_441673426-1-min.jpg","width":900,"height":596},{"@type":"BreadcrumbList","@id":"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/sglt2-hammare-natrium-glukostransportorer-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/www.heartfailurematters.org\/sv\/"},{"@type":"ListItem","position":2,"name":"Vad din l\u00e4kare kan g\u00f6ra","item":"https:\/\/www.heartfailurematters.org\/sv\/vad-din-lakare-eller-sjukskoterska-kan-gora\/"},{"@type":"ListItem","position":3,"name":"SGLT2 (Sodium Glucose Cotransporter 2) inhibitors"}]},{"@type":"WebSite","@id":"https:\/\/www.heartfailurematters.org\/sv\/#website","url":"https:\/\/www.heartfailurematters.org\/sv\/","name":"Heart Failure Matters","description":"Practical information for patients, families and caregivers.","publisher":{"@id":"https:\/\/www.heartfailurematters.org\/sv\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.heartfailurematters.org\/sv\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/www.heartfailurematters.org\/sv\/#organization","name":"Heart Failure Matters","url":"https:\/\/www.heartfailurematters.org\/sv\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/www.heartfailurematters.org\/sv\/#\/schema\/logo\/image\/","url":"https:\/\/cdn-endpoint-hfm.azureedge.net\/heartfailurematters\/2024\/07\/hfm-logo1.jpg","contentUrl":"https:\/\/cdn-endpoint-hfm.azureedge.net\/heartfailurematters\/2024\/07\/hfm-logo1.jpg","width":1280,"height":720,"caption":"Heart Failure Matters"},"image":{"@id":"https:\/\/www.heartfailurematters.org\/sv\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/heartfailurematters"]}]}},"_links":{"self":[{"href":"https:\/\/www.heartfailurematters.org\/sv\/wp-json\/wp\/v2\/pages\/8134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.heartfailurematters.org\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.heartfailurematters.org\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.heartfailurematters.org\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.heartfailurematters.org\/sv\/wp-json\/wp\/v2\/comments?post=8134"}],"version-history":[{"count":4,"href":"https:\/\/www.heartfailurematters.org\/sv\/wp-json\/wp\/v2\/pages\/8134\/revisions"}],"predecessor-version":[{"id":13976,"href":"https:\/\/www.heartfailurematters.org\/sv\/wp-json\/wp\/v2\/pages\/8134\/revisions\/13976"}],"up":[{"embeddable":true,"href":"https:\/\/www.heartfailurematters.org\/sv\/wp-json\/wp\/v2\/pages\/2685"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.heartfailurematters.org\/sv\/wp-json\/wp\/v2\/media\/10874"}],"wp:attachment":[{"href":"https:\/\/www.heartfailurematters.org\/sv\/wp-json\/wp\/v2\/media?parent=8134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.heartfailurematters.org\/sv\/wp-json\/wp\/v2\/categories?post=8134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.heartfailurematters.org\/sv\/wp-json\/wp\/v2\/tags?post=8134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}